Accelerating Drug Development Programs with Data Science & AI

Speaker: Kannan Natarajan, Ph.D., is the Head of Global Biometrics and Data Management (GBDM) and is a member of the Pfizer Research & Development Leadership Team at Pfizer Inc. The GBDM organization supports the global clinical development strategy and data sciences across all of Pfizer’s product portfolio. He is also the Chief Statistical Officer at Pfizer, managing statistical functional excellence across all Pfizer business units. Prior to joining Pfizer, Kannan was Senior Vice President and Global Head of Oncology Biometrics and Data Management at Novartis Pharmaceuticals. Kannan has been in the pharmaceutical industry for over three decades working across various therapeutic areas. Kannan holds a Ph.D., in Statistics from the University of Florida.